Literature DB >> 24448911

Endoscopic correction of complex cases of vesicoureteral reflux utilizing Vantris as a new non-biodegradable tissue-augmenting substance.

Boris Chertin1, Wael Abu Arafeh, Stanislav Kocherov.   

Abstract

PURPOSE: We aimed to evaluate prospectively the efficacy of Vantris as a new non-biodegradable tissue-augmenting substance in children with complex cases of VUR.
MATERIALS AND METHODS: Over the last 4 years, 37 children (28 female and 9 male) with a mean age of 5.8 ± 3.1 years (mean ± SD) underwent endoscopic correction of complex VUR. A total of 38 renal refluxing units (RRU) was treated as 5 had persistent reflux after open surgery, 16 had duplication, 4 had Hutch diverticulum, 6 had small poorly functioning kidneys (less than 20% of relative renal function) with grade V VUR, 2 had ureterocele after puncture, 3 had persistent stump reflux, 1 had prune belly syndrome, and 1 had urogenital sinus. VUR was Grade I in 2, Grade II in 9, Grade III in 11, Grade IV in 10, and Grade V in 6 RRU, respectively.
RESULTS: The reflux was corrected in 34 (89.4%) RRU after a single injection, after second injection in 2 (5.3%) RRU. In 2 (5.3%) RRU, VUR downgraded to Grade I (1RRU) and Grade II (1RRU) and they were taken off antibiotic prophylaxis. VCUG was performed in 11 (73.3%) of 15 children who completed 1 year and in 3 (33.3%) of 9 who completed 3 years of follow up as a part of the routine protocol. None showed VUR recurrence. US demonstrated normal appearance of kidneys in all patients.
CONCLUSION: Our data show that Vantris injection provides a high level of reflux resolution in complex cases of VUR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24448911     DOI: 10.1007/s00383-014-3468-z

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  15 in total

1.  The vesicoureteral hiatus and paraureteral diverticula.

Authors:  F D Stephens
Journal:  J Urol       Date:  1979-06       Impact factor: 7.450

2.  Injection therapy: advancing the treatment of vesicoureteral reflux.

Authors:  Andrew Kirsch; Terry Hensle; Hal Scherz; Martin Koyle
Journal:  J Pediatr Urol       Date:  2006-02-20       Impact factor: 1.830

3.  Endoscopic correction of vesicoureteral reflux: our experience with 115 ureters.

Authors:  A Farkas; E Z Moriel; S Lupa
Journal:  J Urol       Date:  1990-08       Impact factor: 7.450

4.  Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment.

Authors:  Göran Läckgren; Arne Stenberg
Journal:  Ther Adv Urol       Date:  2009-08

Review 5.  Endoscopic management of vesicoureteral reflux: does it stand the test of time?

Authors:  Boris Chertin; Prem Puri
Journal:  Eur Urol       Date:  2002-12       Impact factor: 20.096

6.  Preliminary data on endoscopic treatment of vesicoureteric reflux with polyacrylate polyalcohol copolymer (Vantris®): surgical outcome following single injection.

Authors:  Boris Chertin; Wael Abu Arafeh; Alexander Zeldin; Stanislav Kocherov
Journal:  J Pediatr Urol       Date:  2010-12-30       Impact factor: 1.830

7.  Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer is effective in either double ureters or a small kidney.

Authors:  Göran Läckgren; Nils Wåhlin; Erik Sköldenberg; Tryggve Nevéus; Arne Stenberg
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

8.  Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux.

Authors:  Marcos Perez-Brayfield; Andrew J Kirsch; Terry W Hensle; Martin A Koyle; Peter Furness; Hal C Scherz
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

9.  Endoscopic treatment of vesicoureteral reflux associated with ureterocele.

Authors:  Boris Chertin; Nochiparambil Mohanan; Amicur Farkas; Prem Puri
Journal:  J Urol       Date:  2007-08-16       Impact factor: 7.450

10.  Endoscopic correction of VUR using vantris as a new non-biodegradable tissue augmenting substance: three years of prospective follow-up.

Authors:  Boris Chertin; Wael Abu Arafeh; Alexander Zeldin; Israel A Ostrovsky; Stanislav Kocherov
Journal:  Urology       Date:  2013-03-07       Impact factor: 2.649

View more
  4 in total

1.  A comparison of the double hydrodistention implantation technique (HIT) and the HIT with a polyacrylate/polyalcohol copolymer (PPC) for the endoscopic treatment of primary vesicoureteral reflux.

Authors:  Melih Akin; Basak Erginel; Cetin Ali Karadag; Abdullah Yildiz; Gül Sumru Ozçelik; Nihat Sever; Nimetullah Mete Genc; Ali Ihsan Dokucu
Journal:  Int Urol Nephrol       Date:  2014-06-26       Impact factor: 2.370

2.  Urinary biomarkers of latent inflammation and fibrosis in children with vesicoureteral reflux.

Authors:  Olga Morozova; Dmitry Morozov; Dmitri Pervouchine; Yulia Einav; Darya Lakomova; Natalya Zakharova; Lubov Severgina; Larisa Maltseva; Ivan Budnik
Journal:  Int Urol Nephrol       Date:  2019-12-12       Impact factor: 2.370

3.  Idiosyncratic reaction after injection of polyacrylate - polyalcohol copolymer.

Authors:  Cristiano Linck Pazeto; Fábio José Nascimento; Lucila Heloisa Simardi Santiago; Sidney Glina
Journal:  Int Braz J Urol       Date:  2018 Jul-Aug       Impact factor: 1.541

4.  Endoscopic correction of vesicoureteral reflux in children using polyacrylate-polyalcohol copolymer (Vantris): 5-years of prospective follow-up.

Authors:  Stanisław Warchoł; Grażyna Krzemień; Agnieszka Szmigielska; Przemysław Bombiński; Krzysztof Toth; Teresa Dudek-Warchoł
Journal:  Cent European J Urol       Date:  2017-07-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.